Syapse
OverviewSuggest Edit
Syapse drives healthcare transformation through precision medicine, enabling provider systems to improve clinical outcomes, streamline operations, and shift to new payment models. Syapse Precision Medicine Platform is a comprehensive software suite used by leading health systems to support the clinical implementation of precision medicine in oncology and other service lines. This category-defining platform enables clinical and genomic data integration, decision support, care coordination, and quality improvement at point of care.
| Type | Private | |
| Founded | 2008 | |
| HQ | San Francisco, US | Map |
| Website | syapse.com | |
| Employee Ratings | More |
Recent NewsAll News
- FDA partners with Syapse to study regulatory use of real-world evidence
- South Korea’s SNUH extends partnership with Syapse to expand access to precision medicine
- Precision Medicine Leader Syapse to Utilize NCCN Biomarkers Compendium for Clinical Care
- Predictive Genetic Testing & Consumer/Wellness Genomics Market Is Expected To Play a Seminal Role in the Ultimate Discovery of Personalized Therapies and Medicines
Latest Updates
| Employees (est.) (Nov 2019) | 204 | (+4%) |
| Job Openings | 9 |
Key People/Management at Syapse
Ken Tarkoff
CEO
Tony Loeser
Chief Technology Officer
Dennis Shin
Chief Commercial Officer
Andreas Heid
Senior Vice President, Customer Operations
James Lim
Senior Vice President, Product Development
John Kuelper
Director, Ascension Ventures
Syapse Office Locations
Syapse has offices in San Francisco and Philadelphia
San Francisco, US (HQ)
303 2nd St Tower Suite 650, San Francisco
Philadelphia, US
Philadelphia, PA, USA
Syapse Financials and Metrics
Summary Metrics
Founding Date | 2008 |
Syapse total Funding | $69.6 m |
Syapse latest funding size | $30 m |
Time since last funding | 2 years ago |
Syapse investors | Safeguard Scientifics, GE Ventures, Merck Global Health Innovation Fund, Roche Venture Fund, Amgen Ventures, Ascension Ventures, Social Capital, Social Capital Partners, Medidata Solutions, Intermountain Healthcare Innovation Fund |
Syapse's latest funding round in November 2017 was reported to be $30 m. In total, Syapse has raised $69.6 m
Syapse Online and Social Media Presence
1.68k Twitter followers
Syapse has 1.68k Twitter Followers. The number of followers has increased 0.5% month over month and increased 1.5% quarter over quarter
Syapse's Trends
Twitter Engagement Stats for @Syapse
1.7k
Tweets
254
Following
1.7k
Followers
3
Tweets last 30 days
2
Avg. likes per Tweet
100%
Tweets with engagement
Syapse News and Updates
August 15, 2019
FDA partners with Syapse to study regulatory use of real-world evidence
The precision medicine company will work with the U.S. Food and Drug Administration to see how secure patient data can be better put to work in the development of oncology treatments.
August 07, 2019
South Korea’s SNUH extends partnership with Syapse to expand access to precision medicine
SNUH serves more than 8,000 cancer patients per year across 16 cancer specialty centres, 10 multidisciplinary cancer treatment centres, and a cancer clinical trials centre.
November 01, 2018
Precision Medicine Leader Syapse to Utilize NCCN Biomarkers Compendium for Clinical Care
PLYMOUTH MEETING, Pa., Nov. 1, 2018 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) today announced a new agreement with Syapse, the leading precision medicine company, to expand the use of best practices in precision medicine when treating people with cancer. Syapse...
March 26, 2018
Predictive Genetic Testing & Consumer/Wellness Genomics Market Is Expected To Play a Seminal Role in the Ultimate Discovery of Personalized Therapies and Medicines
The offerings of predictive genetic testing and consumer/wellness genomics market is expected to play a seminal role in the ultimate discovery of personalized therapies and medicines. World over, several direct-to-consumer (DTC) genetic testing and healthcare providers offer genetic testing products…
December 07, 2017
VC-backed Syapse hires oncology VP
San Francisco-based Syapse, a provider of precision medicine solutions, has named Dr. Aradhana Ghosh as vice president of oncology. Ghosh is a former medical oncologist at IBM Watson Health. Syapse's backers include Social Capital, Safeguard Scientifics, Ascension Ventures, GE Ventures, Intermountai…
Syapse Frequently Asked Questions
When was Syapse founded?
Syapse was founded in 2008.
Who are Syapse key executives?
Syapse's key executives are Ken Tarkoff, Tony Loeser and Dennis Shin.
How many employees does Syapse have?
Syapse has 204 employees.
Who are Syapse competitors?
Competitors of Syapse include Flatiron Health, Orion Health and Wellist.
Where is Syapse headquarters?
Syapse headquarters is located at 303 2nd St Tower Suite 650, San Francisco, San Francisco.
Where are Syapse offices?
Syapse has offices in San Francisco and Philadelphia.
How many offices does Syapse have?
Syapse has 2 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies